NVDA
NVIDIA
-- 142.620 TSLA
Tesla
-- 406.580 PLTR
Palantir
-- 78.980 AAPL
Apple
-- 222.780 MSTR
MicroStrategy
-- 353.670 
NEWS TODAY
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
Wednesday, 8th January at 6:30 am
SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), comments on the many viruses that could cause pandemics that are going around already.
This season, two different genotypes of H5N1 bird flu, namely (a) the severe and lethal form D1.1 that has spread globally in birds, and (b) the less severe B3.13 genotype widely spread in diary cattle in North America are causing major concerns even as Seasonal Influenza cases abound.
In addition to that, in the USA, and globally, there are significant numbers of cases of COVID-19, RSV, and hMPV as expected seasonally, that cause various respiratory syndromes from common colds to bronchitis to pneumonia. Norovirus, a primarily gastro-enteric infection that causes vomiting and severe diarrhea has surged up as well.
All of these are RNA viruses that evolve rapidly in the field. All of these can develop resistance to vaccines, antibodies, and existing small chemical drugs (if any) soon after they face such countermeasures in the field.
This is because the resistant virus species that develop in a patient survive and thereafter infect new hosts, thereby proliferating and spreading further, as we have witnessed repeatedly during the COVID-19 pandemic.
Developing specific vaccines and antibodies against each virus strain of each virus type as it evolves in the field is untenable and has poor economic and public health benefits that are short-lived at best [1] .
Wednesday, 8th January at 6:30 am
SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), comments on the many viruses that could cause pandemics that are going around already.
This season, two different genotypes of H5N1 bird flu, namely (a) the severe and lethal form D1.1 that has spread globally in birds, and (b) the less severe B3.13 genotype widely spread in diary cattle in North America are causing major concerns even as Seasonal Influenza cases abound.
In addition to that, in the USA, and globally, there are significant numbers of cases of COVID-19, RSV, and hMPV as expected seasonally, that cause various respiratory syndromes from common colds to bronchitis to pneumonia. Norovirus, a primarily gastro-enteric infection that causes vomiting and severe diarrhea has surged up as well.
All of these are RNA viruses that evolve rapidly in the field. All of these can develop resistance to vaccines, antibodies, and existing small chemical drugs (if any) soon after they face such countermeasures in the field.
This is because the resistant virus species that develop in a patient survive and thereafter infect new hosts, thereby proliferating and spreading further, as we have witnessed repeatedly during the COVID-19 pandemic.
Developing specific vaccines and antibodies against each virus strain of each virus type as it evolves in the field is untenable and has poor economic and public health benefits that are short-lived at best [1] .
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
7059
Followers
46
Following
76K
Visitors
Follow
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day